Rac1 Inhibitor (NSC33766) Up-regulates the Level of Glomerular Nephrin in Diabetic Mice

王筱霞,陈玉强,汪年松,张栋梁,姚兴梅
DOI: https://doi.org/10.3969/j.issn.1009-587x.2010.07.009
2010-01-01
Abstract:Objective:To investigate the effect of Rac1 inhibitor (NSC33766) on expression of glomerular nephrin in STZ-induced diabetic mice.Methods:Diabetic mice models were established by single dose of intraperitoneal administration of STZ in mice.Mice which were given the same dose of normal saline were set as the control.Urine albumin excretion (UAE),plasma creatinine and blood glucose levels were measured in NSC33766-treated mice.Histological changes in the mice glomeruli were observed after HE and PAS staining and ultrastructural changes were examined using transelectronic microscope.In addition,immunohistostainings were performed in paraffin-embedded kidney sections for the analysis of primary cytoskeleton proteins of nephrin.Results:Compare with that of control animals,UAE decreased significantly in NSC33766-treated mice,which were in accordance with attenuated pathological changes such as deposition of extracellular matrix,basement membrane thickness and podocyte foot processes fusion in glomeruli.Up-regulation of the level of nephrin was detected in glomeruli with NSC33766 as compared with that in the DM group.Conclusion:Rac1 inhibitor (NSC33766) might improve the glomerular filtration barrier via up-regulating the podocyte cytoskeleton protein,which lead to protection of renal function in mouse with STZ-induced diabetic nephropathy.
What problem does this paper attempt to address?